Ok Biotech Co Ltd (4155) — Capital Reinvestment Ratio

Latest as of December 2025: 0.37x

Ok Biotech Co Ltd (4155) has a Capital Reinvestment Ratio of 0.37x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$256.86 Million) in capital expenditures (NT$94.26 Million). See Ok Biotech Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.37x
Capex / Operating Cash Flow

Operating Cash Flow

NT$256.86 Million
TWD

Capital Expenditures

NT$94.26 Million
TWD

Data as of

Dec 2025
Most recent filing

Ok Biotech Co Ltd Capital Reinvestment Ratio (2009–2025)

This chart tracks Ok Biotech Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Check Ok Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Ok Biotech Co Ltd (2009–2025)

Year-by-year Capital Reinvestment Ratio for Ok Biotech Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see Ok Biotech Co Ltd (4155) market capitalisation.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 1.28x NT$319.57 Million NT$409.14 Million ▼ -77.5%
2024 5.69x NT$65.90 Million NT$374.72 Million ▼ -96.2%
2023 149.02x NT$2.93 Million NT$437.08 Million ▲ +12081.7%
2022 1.22x NT$240.53 Million NT$294.24 Million ▼ -69.0%
2021 3.95x NT$21.90 Million NT$86.46 Million ▲ +631.0%
2020 0.54x NT$147.70 Million NT$79.79 Million ▼ -68.7%
2019 1.73x NT$45.18 Million NT$77.95 Million ▲ +683.3%
2018 0.22x NT$128.75 Million NT$28.36 Million ▼ -74.3%
2017 0.86x NT$102.77 Million NT$88.04 Million ▲ +291.9%
2016 0.22x NT$260.72 Million NT$56.99 Million ▼ -26.8%
2015 0.30x NT$289.44 Million NT$86.46 Million ▼ -87.2%
2013 2.33x NT$87.08 Million NT$202.91 Million ▲ +108.4%
2012 1.12x NT$79.17 Million NT$88.53 Million ▲ +181.5%
2011 0.40x NT$93.12 Million NT$36.99 Million ▼ -92.1%
2009 5.04x NT$6.95 Million NT$35.06 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow